11/20/2024 7:47 AM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-T/A | |
11/20/2024 7:01 AM | Longboard Pharmaceuticals (Subject)
| Form SC 14D9/A | |
11/19/2024 7:13 PM | Kaye Randall (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2024 5:18 AM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-T/A | |
11/14/2024 2:10 PM | Cormorant Asset Management, LP (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024 7:48 PM | Lind Kevin Robert (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2024 8:26 AM | FMR LLC (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
11/07/2024 8:12 AM | FMR LLC (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024 7:56 AM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-T/A | |
11/06/2024 5:06 AM | Longboard Pharmaceuticals (Subject)
| Form SC 14D9/A | |
11/04/2024 12:25 PM | Longboard Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/30/2024 7:57 AM | Longboard Pharmaceuticals (Subject)
| Form SC 14D9 | |
10/30/2024 6:40 AM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-T | |
10/29/2024 3:38 PM | Lind Kevin Robert (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:40 PM | Longboard Pharmaceuticals (Issuer) Roberts Brandi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/29/2024 3:43 PM | Kaye Randall (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2024 4:18 PM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/22/2024 2:24 PM | BlackRock, Inc. (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC 13G | |
10/16/2024 4:16 PM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/16/2024 3:40 PM | Kaye Randall (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 8:39 PM | Longboard Pharmaceuticals (Subject)
| Form SC14D9C | |
10/15/2024 4:08 PM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/15/2024 9:22 AM | H LUNDBECK A S (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/15/2024 5:20 AM | Longboard Pharmaceuticals (Subject)
| Form SC14D9C | |
10/15/2024 5:14 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 6:36 PM | Kaye Randall (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 3:35 PM | Kaye Randall (Reporting) Longboard Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 5:01 PM | Kaye Randall (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 5:03 PM | Lind Kevin Robert (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 3:12 PM | Kaye Randall (Reporting) Longboard Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:20 PM | Longboard Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024 3:17 PM | Longboard Pharmaceuticals (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
07/01/2024 8:15 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 8:05 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 3:05 PM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 3:15 PM | Longboard Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024 8:16 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/12/2024 3:21 PM | Longboard Pharmaceuticals (Filer)
| Form ARS | |
04/12/2024 3:16 PM | Longboard Pharmaceuticals (Filer)
| Form DEFA14A | |
03/26/2024 4:25 PM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 3:45 PM | Longboard Pharmaceuticals (Filer)
| Form S-3ASR | |
Breaking News: Tesla headed to $500… (Ad) That headline hit late last night…and the rally has begun
Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. |
03/12/2024 3:15 PM | Longboard Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/11/2024 7:19 AM | FMR LLC (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 5:03 AM | Longboard Pharmaceuticals (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024 8:55 AM | Longboard Pharmaceuticals (Subject) Prosight Management, LP (Filed by)
| Form SC 13G/A | |
01/30/2024 10:23 AM | Farallon Capital Partners, L.P. (Filed by) Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024 3:37 PM | ARENA PHARMACEUTICALS INC (Reporting) Longboard Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:12 PM | Longboard Pharmaceuticals (Subject) PFIZER INC (Filed by)
| Form SC 13D/A | |
01/04/2024 3:51 PM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:48 PM | Longboard Pharmaceuticals (Filer)
| Form 424B5 | |
01/03/2024 7:59 PM | Longboard Pharmaceuticals (Filer)
| Form S-3MEF | |
01/02/2024 3:54 PM | Longboard Pharmaceuticals (Filer)
| Form 424B5 | |
01/02/2024 8:44 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 7:35 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |